Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular and Cellular Biology

• Publication date

  2007-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.00440-07PMID 17785433PMCID PMC2169056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

  2007cited by this paper
• Hypoxia signalling controls metabolic demand.

  2007cited by this paper
• HIF-dependent Anti-tumorigenic Effect of Anti-oxidants In Vivo

  2007cited by this paper
• HIF-dependent antitumorigenic effect of antioxidants in vivo.

  2007cited by this paper
• HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.

  2007cited by this paper
• HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.

  2007cited by this paper
• Hypoxia-inducible factors: central regulators of the tumor phenotype.

  2007cited by this paper
• Hypoxia-induced energy stress regulates mRNA translation and cell growth.

  2006cited by this paper
• The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.

  2006cited by this paper
• Global mapping of c-Myc binding sites and target gene networks in human B cells

  2006cited by this paper
• Cancer's sweet tooth.

  2006cited by this paper
• HIF-2 (cid:1) regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth

  2006cited by this paper
• HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

  2006cited by this paper
• Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo

  2006cited by this paper
• Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

  2006cited by this paper
• Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis.

  2006cited by this paper
• Cancer's molecular sweet tooth and the Warburg effect.

  2006cited by this paper
• Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.

  2006cited by this paper
• HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

  2006cited by this paper
• Glucose metabolism and cancer.

  2006cited by this paper
• Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.

  2006cited by this paper
• The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1 (cid:1)

  2006cited by this paper
• HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

  2006influential reference
• Genomic binding and transcriptional regulation by the Drosophila Myc and Mnt transcription factors.

  2005cited by this paper
• Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth.

  2005cited by this paper
• HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.

  2005cited by this paper
• Mxi1 is induced by hypoxia in a HIF-1–dependent manner and protects cells from c-Myc-induced apoptosis

  2005cited by this paper
• Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis

  2005cited by this paper
• Transcriptional regulation and transformation by Myc proteins

  2005cited by this paper
• Genetic Instability: The Dark Side of THE Hypoxic Response

  2005cited by this paper
• Cancer therapeutics: targeting the dark side of Myc.

  2005cited by this paper
• HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression

  2005cited by this paper
• HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

  2004cited by this paper
• Akt Inhibits Apoptosis Downstream of BID Cleavage via a Glucose-Dependent Mechanism Involving Mitochondrial Hexokinases

  2004cited by this paper
• Evaluation of Myc E-Box Phylogenetic Footprints in Glycolytic Genes by Chromatin Immunoprecipitation Assays

  2004cited by this paper
• Oxygen sensing by HIF hydroxylases

  2004cited by this paper
• The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease.

  2004cited by this paper
• c-Myc Interacts with Hypoxia to Induce Angiogenesis In vivo by a Vascular Endothelial Growth Factor-Dependent Mechanism

  2004cited by this paper
• HIF‐1α induces cell cycle arrest by functionally counteracting Myc

  2004cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Dynamic Balancing of the Dual Nature of HIF-1alpha for Cell Survival

  2004cited by this paper
• Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival

  2003cited by this paper
• A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells

  2003cited by this paper
• Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1

  2003cited by this paper
• Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation.

  2003cited by this paper
• Hypoxia-Inducible Factor 1α Is Essential for Cell Cycle Arrest during Hypoxia

  2003cited by this paper
• Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation

  2003cited by this paper
• Hexokinase II: the integration of energy metabolism and control of apoptosis.

  2003cited by this paper
• Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.

  2003cited by this paper
• Regulation of angiogenesis by hypoxia: role of the HIF system

  2003influential reference
• HIF-1 as a target for drug development

  2003cited by this paper
• BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia.

  2003cited by this paper
• HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia

  2003cited by this paper
• Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis*

  2002cited by this paper
• Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.

  2002cited by this paper
• HIF-1 and tumor progression: pathophysiology and therapeutics.

  2002cited by this paper
• c-MYC: more than just a matter of life and death

  2002cited by this paper
• Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.

  2002cited by this paper
• Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling

  2002cited by this paper
• c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression.

  2002cited by this paper
• Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.

  2002cited by this paper
• The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.

  2002cited by this paper
• Repression of α-Fetoprotein Gene Expression under Hypoxic Conditions in Human Hepatoma Cells: Characterization of a Negative Hypoxia Response Element That Mediates Opposite Effects of Hypoxia Inducible Factor-1 and c-Myc

  2002cited by this paper
• Deconstructing myc.

  2001cited by this paper
• HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus.

  2001cited by this paper
• Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.

  2001cited by this paper
• HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

  2001cited by this paper
• Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression*

  2001cited by this paper
• Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation

  2001cited by this paper
• Faculty Opinions recommendation of Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

  2001cited by this paper
• Glucose Catabolism in Cancer Cells

  2001cited by this paper
• Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation

  2001cited by this paper
• Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc*

  2000cited by this paper
• Cell cycle activation by c‐myc in a Burkitt lymphoma model cell line

  2000cited by this paper
• MYC oncogenes and human neoplastic disease

  1999cited by this paper
• c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism

  1999cited by this paper
• Control of cell growth by c-Myc in the absence of cell division.

  1999cited by this paper
• The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation

  1999cited by this paper
• HIF‐1α is required for solid tumor formation and embryonic vascularization

  1998cited by this paper
• HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

  1998cited by this paper
• Oxygen, genes, and development: An analysis of the role of hypoxic gene regulation during murine vascular development

  1998cited by this paper
• Traps to catch unwary oncogenes.

  1998cited by this paper
• Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.

  1997cited by this paper
• Myc target genes.

  1997cited by this paper
• c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

  1997cited by this paper
• Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.

  1997cited by this paper
• Hexokinase Binding to Mitochondria: A Basis for Proliferative Energy Metabolism

  1997cited by this paper
• Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

  1996cited by this paper
• Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.

  1994cited by this paper
• General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.

  1993cited by this paper
• Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location.

  1983cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• On respiratory impairment in cancer cells.

  1956cited by this paper
• On respiratory impairment in cancer cells.

  1956cited by this paper

• Environmental hypoxia controls the evolution of cavefish heart asymmetry

  2026cites this paper
• Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances.

  2026cites this paper
• Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer.

  2026cites this paper
• Molecular mechanisms and targeted therapeutic strategies for glycolytic reprogramming in osteosarcoma

  2026cites this paper
• Role and Molecular Mechanisms of Aerobic Glycolysis in Gastrointestinal Tumors

  2026cites this paper
• All-trans retinoic acid enhances the anti-angiogenic effects of hemoporfin-mediated photodynamic therapy via the ATM-SerRS-VEGFA axis in endothelial cells.

  2026cites this paper
• MiR-181a-5p/CDK6 axis attenuates cell proliferation, migration and glycolytic reprogramming in oral squamous cell carcinoma.

  2026cites this paper
• CD147 Mediates the Metabolic Reprogramming of Cancer Associated Fibroblasts Induced by EVs Released by Differentiating Cancer Stem Cells

  2025cites this paper
• Targeting Wnt-driven metabolic adaptations in cancer: integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies

  2025cites this paper
• Lactylation: a novel driver of drug resistance in the tumor microenvironment

  2025cites this paper
• C‐Myc Indirectly Controls ATP13A2 Levels via HIF‐1α Activation

  2025cites this paper
• B cell immunometabolism in health and disease

  2025cites this paper
• The anti-tumour role of ketogenic diet based on energy metabolism.

  2025cites this paper
• Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies

  2025cites this paper
• Energy metabolism in health and diseases

  2025cites this paper
• Cedrol impedes lung cancer metastasis by reducing tumor-associated macrophage polarization mediated by MYC-driven aerobic glycolysis

  2025cites this paper
• Metabolic Plasticity and Cancer Stem Cell Metabolism: Exploring the Glycolysis-OXPHOS Switch as a Mechanism for Resistance and Tumorigenesis

  2025cites this paper
• Fueling the fire–a pan-cancer analysis of MYC-regulated lipid metabolism

  2025cites this paper
• UHRF1-mediated HIF-1α stabilization promotes ovarian cancer through metabolic reprogramming and angiogenesis

  2025cites this paper
• PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth.

  2025cites this paper
• Glycolytic Reprogramming in Uterine Fibroids: Genetic, Transcriptomic, Proteomic, and Metabolomic Insights

  2025cites this paper
• Lactylation in cancer biology: Unlocking new avenues for research and therapy

  2025cites this paper
• Metabolic Reprogramming and Cell Interaction in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies

  2025cites this paper
• ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis

  2025cites this paper
• Role of the bone marrow microenvironment in multiple myeloma: Impact of niches on drug resistance mechanisms.

  2025cites this paper
• Cardamonin represses gastric adenocarcinoma development by modulating c-Myc/GLUT4/PGC-1α axis mediated glucose uptake and energy metabolism reprogramming.

  2025cites this paper
• Autophagy induced by metabolic processes leads to solid tumor cell metastatic dormancy and recurrence

  2025cites this paper
• Targeting the BCKDK/BCLAF1/MYC/HK2 axis to alter aerobic glycolysis and overcome Trametinib resistance in lung cancer

  2025cites this paper
• Ancient genomic linkage of α-globin and Nprl3 couples metabolism with erythropoiesis

  2025cites this paper
• The role and mechanism of aerobic glycolysis in nasopharyngeal carcinoma

  2025cites this paper
• GLUT1 as a Potential Therapeutic Target in Glioblastoma

  2025cites this paper
• Investigation and Distinction of Energy Metabolism in Proliferating Hepatocytes and Hepatocellular Carcinoma Cells

  2025cites this paper
• Regulation of pyruvate dehydrogenase complex: Dancing to different drums in cancer

  2025cites this paper
• Molecular Mediators of Metabolic Reprogramming in Cancer: Mechanisms, Regulatory Networks, and Therapeutic Strategies

  2025cites this paper
• Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism

  2025cites this paper
• Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks.

  2024cites this paper
• Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma.

  2024cites this paper
• Rocaglamide reprograms glucose metabolism in erythroleukemic cells via c-MYC transcriptional regulation of TXNIP and HK2.

  2024cites this paper
• Intratumoral microbiota: a new force in the development and treatment of esophageal cancer

  2024cites this paper
• Transcriptional regulation of hypoxic cancer cell metabolism and artificial intelligence.

  2024cites this paper
• Advances in the interaction of glycolytic reprogramming with lactylation.

  2024cites this paper
• Chrysophanol inhibits of colorectal cancer cell motility and energy metabolism by targeting the KITENIN/ErbB4 oncogenic complex

  2024cites this paper
• Altered metabolism in cancer: insights into energy pathways and therapeutic targets

  2024cites this paper
• Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer

  2024cites this paper
• Lactate and Lactylation: Behind the Development of Tumors.

  2024cites this paper
• The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis

  2024cites this paper
• Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells

  2024cites this paper
• The emerging role of lactate in tumor microenvironment and its clinical relevance.

  2024cites this paper
• Targeting MYC at the intersection between cancer metabolism and oncoimmunology

  2024cites this paper
• Tumor biomarkers for diagnosis, prognosis and targeted therapy

  2024cites this paper
• PI3K-dependent reprogramming of hexokinase isoforms controls glucose metabolism and functional responses of B lymphocytes

  2024cites this paper
• Gene expression profiling in Venous thromboembolism: Insights from publicly available datasets

  2024cites this paper
• LINC01764 promotes colorectal cancer cells proliferation, metastasis, and 5‐fluorouracil resistance by regulating glucose and glutamine metabolism via promoting c‐MYC translation

  2024cites this paper
• Investigating the Transcriptomic Variances in two Phases Ecytonucleospora hepatopenaei (EHP) in Litopenaeus vannamei.

  2024cites this paper
• Elongation factor 1A1 regulates metabolic substrate preference in mammalian cells

  2024cites this paper
• Metabolic reprogramming in the tumor microenvironment of liver cancer

  2024cites this paper
• The DUX4–HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected

  2024cites this paper
• Insights into Metabolic Reprogramming in Tumor Evolution and Therapy

  2024cites this paper
• Metabolic Reprogramming Directed by Super-enhancers in Tumors: An Emerging Landscape.

  2024cites this paper
• Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential

  2023cites this paper
• Ubiquitin-specific protease 28: the decipherment of its dual roles in cancer development

  2023cites this paper
• Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors

  2023cites this paper
• Andrographolide suppresses aerobic glycolysis and induces apoptotic cell death by inhibiting pyruvate dehydrogenase kinase 1 expression

  2023cites this paper
• Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype

  2023cites this paper
• The Role of Reprogrammed Glucose Metabolism in Cancer

  2023cites this paper
• ATAD2 promotes glycolysis and tumor progression in clear cell renal cell carcinoma by regulating the transcriptional activity of c-Myc

  2023cites this paper
• The Aurora kinase inhibitor AT9283 inhibits Burkitt lymphoma growth by regulating Warburg effect

  2023cites this paper
• Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma

  2023cites this paper
• RECORDS OF PHARMACEUTICAL AND BIOMEDICAL SCIENCES Mechanism of Valproic acid Induced Autism: Canonical Wnt-β-Catenin Pathway

  2023cites this paper
• Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy.

  2023cites this paper
• Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse.

  2023cites this paper
• CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma

  2023cites this paper
• Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy

  2023cites this paper
• Ancient genomic linkage couples metabolism with erythroid development

  2023cites this paper
• Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma

  2023cites this paper
• MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products

  2023cites this paper
• Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma

  2023cites this paper
• Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals.

  2023cites this paper
• Redox-Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities and Challenges.

  2023cites this paper
• Therapeutic and diagnostic applications of exosomal circRNAs in breast cancer

  2023cites this paper
• Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets

  2023cites this paper
• The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics

  2023cites this paper
• PDGF‐BB/PDGFRβ promotes epithelial–mesenchymal transition by affecting PI3K/AKT/mTOR‐driven aerobic glycolysis in Wilms' tumor G401 cells

  2022cites this paper
• Metabolic regulation of the proteasome under hypoxia by Poldip2 controls fibrotic signaling in vascular smooth muscle cells.

  2022cites this paper
• Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc

  2022cites this paper
• Regulation and function of the mammalian tricarboxylic acid cycle

  2022cites this paper
• Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy

  2022cites this paper
• Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition

  2022cites this paper
• The deubiquitinating enzyme USP17 regulates c‐Myc levels and controls cell proliferation and glycolysis

  2022cites this paper
• Multiomics analysis couples mRNA turnover and translational control of glutamine metabolism to the differentiation of the activated CD4+ T cell

  2022cites this paper
• Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma

  2022cites this paper
• Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy

  2022cites this paper
• Tumor glycolysis, an essential sweet tooth of tumor cells.

  2022cites this paper
• FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.

  2022cites this paper
• MicroRNA Profiling Shows a Time-Dependent Regulation within the First 2 Months Post-Birth and after Mild Neonatal Hypoxia in the Hippocampus from Mice

  2022cites this paper
• RIG-I Promotes Cell Viability, Colony Formation, and Glucose Metabolism and Inhibits Cell Apoptosis in Colorectal Cancer by NF-κB Signaling Pathway

  2022cites this paper
• Metabolic switch in cancer - Survival of the fittest.

  2022cites this paper
• Molecular basis and clinical implications of HIFs in cardiovascular diseases.

  2022cites this paper
• Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells

  2022cites this paper
• TGF-β signaling in the tumor metabolic microenvironment and targeted therapies

  2022cites this paper